Obesity News and Research

Latest Obesity News and Research

Heavy coffee drinking may weaken bone density in older women

Researchers investigate the longitudinal associations of coffee and tea consumption with bone mineral density in older women.

12 Jan 2026

Weight loss drugs and surgery improve body composition in patients with obesity

Both the new weight loss drugs and bariatric (weight loss) surgery improve body composition in patients with obesity by inducing a moderate loss of fat-free mass (including lean muscle) along with a substantial reduction in fat, researchers at Vanderbilt Health have found.

9 Jan 2026

George Mason trial: New pill aims to sustain weight loss after GLP-1s

GLP-1 medications like Ozempic and Wegovy have transformed obesity treatment, but maintaining weight loss after the medications stop remains a challenge.

9 Jan 2026

Research shows benefits of lifestyle interventions in reducing the risk of gestational diabetes

New research co-authored by Professor Fionnuala McAuliffe, UCD School of Medicine, and led by the University of Liverpool, has demonstrated the significant benefits of lifestyle interventions in reducing the risk of gestational diabetes.

9 Jan 2026

California ends Medicaid coverage of weight loss drugs despite TrumpRx plan

Many low-income Californians prescribed wildly popular weight loss drugs lost their coverage for the medications at the start of the new year.

9 Jan 2026

Global analysis shows widespread eligibility for GLP-1 weight management drugs

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like diabetes, cardiovascular disease, and cancers.

8 Jan 2026

Study reveals innate immune barriers to long-term pig kidney transplant survival

Pioneering research led by Brazilians describes the immune system's reactions in detail in the first living patient to receive a genetically modified pig kidney transplant.

8 Jan 2026

Why promising microbiome therapies rarely work in patients

Addressing the microbiome's translational gap involves understanding biological complexity and developing function-driven, patient-specific interventions.

8 Jan 2026

Weight loss drugs may cause nutritional deficiencies without proper guidance

People prescribed the new generation of weight loss drugs may not receive sufficient nutritional guidance to support safe and sustainable weight loss, leaving them vulnerable to nutritional deficiencies and muscle loss, say experts at UCL and the University of Cambridge.

7 Jan 2026

Millions in Great Britain using or seeking weight loss drugs

An estimated 1.6 million adults in England, Wales and Scotland used drugs such as Wegovy and Mounjaro to help lose weight between early 2024 and early 2025, according to a new study by UCL (University College London) researchers.

7 Jan 2026

Stopping weight loss drugs leads to rapid weight regain and health reversal

Stopping weight loss drugs is followed by weight regain and reversal of beneficial effects on heart and metabolic health markers such as high cholesterol and high blood pressure, finds a study published by The BMJ today.

7 Jan 2026

Replenishing mitochondria significantly reduces chronic nerve pain, research shows

For millions living with nerve pain, even a light touch can feel unbearable. Scientists have long suspected that damaged nerve cells falter because their energy factories known as mitochondria don't function properly.

7 Jan 2026

Light daily movement linked to lower mortality risk in people with CKM syndrome

Light intensity activities, like walking or household chores, were linked to a lower risk of death for people with cardiovascular-kidney-metabolic (CKM) syndrome, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

7 Jan 2026

Enveda’s third asset to the clinic with US FDA IND clearance: What it means for Inflammatory Bowel Disease

Enveda, a multi-asset clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life’s chemistry, has announced that the US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for ENV-6946.

From Hanson Wade Group - 4th Precision Medicine in Inflammatory Bowel Disease Summit 6 Jan 2026

The gut is not just digestive and new evidence shows it actively controls brain function

This comprehensive review synthesizes a decade of human and animal research to explain how the gut and brain communicate through hormonal, neural, immune, and microbial pathways. It highlights how disruptions in these pathways contribute to gastrointestinal, metabolic, and neurological disorders, and how modern therapies are beginning to exploit gut–brain signaling for clinical benefit.

6 Jan 2026

Forever chemicals linked to higher liver disease risk in adolescents

A new study co-led by the Southern California Superfund Research and Training Program for PFAS Assessment, Remediation and Prevention (ShARP) Center and the University of Hawai'i has linked certain common "forever chemicals" to a higher risk of liver disease in adolescents.

6 Jan 2026

Siblings of people with Prader-Willi syndrome face hidden emotional burdens

New research from the University of East Anglia (UK) reveals the hidden struggles experienced by the brothers and sisters of people with Prader-Willi syndrome.

6 Jan 2026

Neighborhood deprivation predicts poorer lower-limb strength

Neighborhood-level disadvantages are linked to reduced lower limb strength and mobility in older adults, emphasizing the need for targeted interventions.

6 Jan 2026

Can ketogenic diets help PCOS? New analysis points to weight and insulin gains

A systematic review and meta-analysis of 15 studies found that ketogenic diets were associated with short-term reductions in body weight, waist circumference, insulin resistance, and some reproductive hormones in women with polycystic ovary syndrome, primarily among those with overweight or obesity. However, substantial heterogeneity, low certainty of evidence, limited safety reporting, and short follow-up periods mean the clinical effectiveness and long-term sustainability of ketogenic diets in PCOS remain uncertain.

5 Jan 2026

Diabetes could drain up to INT$78.8 trillion from the global economy by 2050, study finds

This global macroeconomic analysis estimates that diabetes mellitus will cost the world economy INT$10.2 trillion between 2020 and 2050, rising to INT$78.8 trillion when unpaid informal caregiving is included. Using a health-augmented economic model across 204 countries, the study shows that informal care is the dominant and most underestimated driver of diabetes-related economic losses worldwide.

5 Jan 2026

Obesity News and Research

Latest Obesity News and Research

Heavy coffee drinking may weaken bone density in older women

Weight loss drugs and surgery improve body composition in patients with obesity

George Mason trial: New pill aims to sustain weight loss after GLP-1s

Research shows benefits of lifestyle interventions in reducing the risk of gestational diabetes

California ends Medicaid coverage of weight loss drugs despite TrumpRx plan

Global analysis shows widespread eligibility for GLP-1 weight management drugs

Study reveals innate immune barriers to long-term pig kidney transplant survival

Why promising microbiome therapies rarely work in patients

Weight loss drugs may cause nutritional deficiencies without proper guidance

Millions in Great Britain using or seeking weight loss drugs

Stopping weight loss drugs leads to rapid weight regain and health reversal

Replenishing mitochondria significantly reduces chronic nerve pain, research shows

Light daily movement linked to lower mortality risk in people with CKM syndrome

Enveda’s third asset to the clinic with US FDA IND clearance: What it means for Inflammatory Bowel Disease

The gut is not just digestive and new evidence shows it actively controls brain function

Forever chemicals linked to higher liver disease risk in adolescents

Siblings of people with Prader-Willi syndrome face hidden emotional burdens

Neighborhood deprivation predicts poorer lower-limb strength

Can ketogenic diets help PCOS? New analysis points to weight and insulin gains

Diabetes could drain up to INT$78.8 trillion from the global economy by 2050, study finds

Innovation in neuroscience drug discovery - eBook eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Obesity News and Research

Latest Obesity News and Research

Innovation in neuroscience drug discovery - eBook eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in